- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03942614
Nordic Pole Walking for Individuals With Cancer
Nordic Pole Walking for Individuals With Cancer: A Feasibility Study Assessing Physical Function and Health-Related Quality of Life
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- a primary diagnosis (including reoccurrence) of histologically confirmed stage I-IV NSCLC, prostate, colorectal, or endometrial cancer (with any concurrent cancer treatment)
- a cancer diagnosis or treatment within the last three years
- ≥ 55 years old
- approval by the primary treating physician
- ability to communicate in English.
Exclusion Criteria:
• engaged in NPW within the last six-months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Nordic pole walking
walking with a pair of poles customized to an individual's height and stride length
|
|
|
No Intervention: Control
usual daily routine and activities of daily living
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility (assessed by qualitative field notes)
Time Frame: 8 weeks
|
Feasibility was assessed using the framework as described by: Thabane L et al (2010) A tutorial on pilot studies: the what, why and how. BMC Medical Research Methodology, vol 10. England, p 1. The Thabane Framework uses 4 criteria to measure feasibility: Process, Resources, Management and Scientific. For each criteria, detailed field notes regarding objectives and measures were maintained throughout the study. These notes on the four Thabane criteria were used to categorize the study to one of four possible outcomes: 1) stop - the study is not feasible; 2) continue, but modify the protocol - the study is feasible with modifications; 3) continue without modifications, but monitor closely - the study is feasible with close monitoring; and 4) continue without modifications - the study is feasible as is. |
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
6-minute walk test (6MWT)
Time Frame: 8 weeks
|
The 6MWT is a measure of submaximal functional capacity.
Average healthy norms (61 to 80 years old) range from 583m (women) to 687m (men).
|
8 weeks
|
|
30-second chair stand test
Time Frame: 8 weeks
|
The 30-s chair stand test is a measure of lower body strength.
In 60 to 94 years olds, average healthy norms range from 13 (women) to 14 (men)
|
8 weeks
|
|
Unsupported Upper Limb Exercise Test (UULEX)
Time Frame: 8 weeks
|
UULEX, an incremental test that measures peak unsupported arm exercise capacity.
UULEX average healthy norms (40 to 89 years old) range from 11 (women) to 12 minutes (men).
|
8 weeks
|
|
Hand grip strength
Time Frame: 8 weeks
|
average healthy norms (60 to 79 years old) ranging from 24kg (women) and 41kg
|
8 weeks
|
|
Functional Assessment of Cancer Therapy-Lung (FACT-L)
Time Frame: 8 weeks
|
The FACT-L is a measure of health-related quality of life and includes 4 general and 1 lung cancer symptom-specific domain.
The general domains (27 questions) include: physical well-being (PWB), social/family well-being (SWB), emotional well-being (EWB), and functional well-being (FWB).
The lung cancer symptom specific (LCS) domain (7 questions) evaluates symptoms that are commonly experienced by lung cancer patients (i.e.
shortness of breath, weight loss, and chest tightness).
Domain scores are then combined to calculate the Total Outcome Index (TOI) (TOI = PWB + FWB + LCS), Functional Assessment of Cancer Therapy - General (FACT-G) score (FACT G = PWB + SWB + EWB + FWB), and FACT-L score (FACT-L = FACT- G + LCS).
TOI range 0 to 135 with higher score better quality of life.
|
8 weeks
|
|
36-Item Short Form Health (SF-36) Questionnaire
Time Frame: 8 weeks
|
The SF-36 is a measure of generic health-related quality of life.
It assesses 8 health concepts (scales): 1) limitations in physical activities because of health problems; 2) limitations in social activities because of physical or emotional problems; 3) limitations in usual role activities because of physical health problems; 4) bodily pain; 5) general mental health; 6) limitations in usual role activities because of emotional problems; 7) vitality; and 8) general health perceptions.
Scoring is a two-step process.
First, precoded numeric values are recoded per a scoring key.
In addition, each item is scored on a 0 to 100 range so that the lowest and highest possible scores (quality of life) are 0 and 100, respectively.
Scores represent the percentage of total possible score achieved.
In step 2, items in the same scale are averaged together to create the 8 scale scores.
More information: https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form/scoring.html.
|
8 weeks
|
|
International Physical Activity Questionnaire (IPAQ)
Time Frame: 8 weeks
|
The IPAQ is a measure physical activity level.
Questions ask about walking, moderate-intensity activities, vigorous-intensity activities, and sitting during the following 4 domains: a) leisure time physical activity; b) domestic and gardening activities; c) work-related physical activity; and d) transport-related physical activity.
Two types of scoring were done: 1) in categories (low activity levels, moderate activity levels or high activity levels), and 2) as a continuous variable (MET minutes a week).
MET minutes represent the amount of energy expended carrying out physical activity and is a multiple of a person's estimated resting energy expenditure.
One MET is what is expended when at rest.
To get MET minutes a week from the IPAQ walking was considered 3.3 METS, moderate physical activity to be 4 METS and vigorous physical activity 8 METS.
(reference: https://ugc.futurelearn.com/uploads/files/bc/c5/bcc53b14-ec1e-4d90-88e3-1568682f32ae/IPAQ_PDF.pdf)
|
8 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Demographic information
Time Frame: baseline
|
A data collection form was used to collect demographic information including cancer diagnosis and treatments, side effects, general health history, and smoking status (baseline only).
No formal scale was used to collect this information; only descriptive information was collected.
|
baseline
|
|
Resting heart rate
Time Frame: baseline and 8 weeks
|
beats per minute
|
baseline and 8 weeks
|
|
Oxygen saturation
Time Frame: baseline and 8 weeks
|
in %
|
baseline and 8 weeks
|
|
Height
Time Frame: baseline and 8 weeks
|
meters
|
baseline and 8 weeks
|
|
Weight
Time Frame: baseline and 8 weeks
|
meters
|
baseline and 8 weeks
|
|
Body mass index
Time Frame: baseline and 8 weeks
|
calculated as height divided by weight squared
|
baseline and 8 weeks
|
|
Bicep circumferences
Time Frame: baseline and 8 weeks
|
cm
|
baseline and 8 weeks
|
|
Chest circumference
Time Frame: baseline and 8 weeks
|
cm
|
baseline and 8 weeks
|
|
Waist circumference
Time Frame: baseline and 8 weeks
|
cm
|
baseline and 8 weeks
|
|
Hip circumference
Time Frame: baseline and 8 weeks
|
cm
|
baseline and 8 weeks
|
|
Thigh circumferences
Time Frame: baseline and 8 weeks
|
cm
|
baseline and 8 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 15-018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neoplasms
-
Peking University First HospitalRecruitingBreast Neoplasms、Lung Neoplasms、Pancreatic NeoplasmsChina
-
Hospices Civils de LyonNot yet recruiting
-
GlaxoSmithKlineCompleted
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)Recruiting
-
Amphia HospitalRecruitingColonic Neoplasms MalignantNetherlands
-
Marquette General Health SystemUpper Michigan Brain Tumor CenterWithdrawnGlioma | MeningiomaUnited States
-
Ain Shams UniversityNot yet recruiting
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompletedBrain Stem Neoplasms, Primary | Neoplasms, Brain StemUnited States
-
Medical College of WisconsinM.D. Anderson Cancer Center; National Cancer Institute (NCI); University of Chicago and other collaboratorsRecruiting
-
GlaxoSmithKlineRecruitingNeoplasms, ColonSpain, Belgium, Japan, Italy, United Kingdom, Switzerland
Clinical Trials on Nordic pole walking
-
University of SaskatchewanSaskatchewan Health Research Foundation; Saskatchewan Centre for Patient-Oriented...Completed
-
Federal University of Rio Grande do SulHospital de Clinicas de Porto Alegre; Federal University of Health Science...CompletedParkinson Disease | Parkinson Disease 10Brazil
-
Azienda Ospedaliera Universitaria Integrata VeronaUniversita di VeronaUnknownHypertension | Metabolic Syndrome | Overweight and Obesity | Cardiovascular Risk Factor | Sarcopenic Obesity | Disability Physical | Abdominal ObesityItaly
-
Human Locomotion ScienceUniversity of Southern Denmark; National Board of Health, Denmark; Nordic Institute... and other collaboratorsUnknown
-
Je Bouge Pour Mon MoralUniversity Grenoble AlpsCompletedDepressive SymptomsFrance
-
Ottawa Heart Institute Research CorporationCompleted
-
Federal University of Rio Grande do SulCompleted
-
University of SaskatchewanSaskatchewan Health Research Foundation; Royal University Hospital Foundation; Saskatchewan Centre for Patient-Oriented ResearchCompletedOsteoporosis | Vertebral Fracture | HyperkyphosisCanada
-
University of TalcaNot yet recruiting
-
University of JazanCompleted